Pfizer (PFE) reported Q1 adjusted earnings Wednesday of $0.82 per diluted share, down from $1.23 a year earlier.
Analysts polled by Capital IQ expected $0.51.
Revenue for the quarter ended March 31 was $14.88 billion, down from $18.49 billion a year earlier.
Analysts surveyed by Capital IQ expected $13.92 billion.
The drug company said it now expects 2024 adjusted EPS of $2.15 to $2.35, up from its prior guidance of $2.05 to $2.25. Analysts polled by Capital IQ expect $2.21.
Revenue for the current year is still projected to be $58.5 billion to $61.5 billion, the company said. Analysts surveyed by Capital IQ are looking for $59.94 billion.
Shares of the company were up 1.7% in recent Wednesday premarket activity.